Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Maxim Palace Kempinski

Oct 14, 2019 8:00 AM - Oct 15, 2019 5:00 PM

1st Settlement, Eastern Ring Road, New Cairo, 11477, Egypt

DIA Pharmacovigilance Workshop (Middle East & Africa Region)

Keeping up-to-date with the pharmacovigilance landscape in MENA region.

Session 2: Arab League GVP Inspection

Session Chair(s)

Dana  Isleem

Dana Isleem

Pharmacovigilance Manager, Bristol-Myers Squibb , Saudi Arabia

Achieving a successful outcome in an audit or inspection is a formal objective for many leaders. But what does ‘success’ look like? The Pharmacovigilance inspections are designed to determine compliance with regulatory pharmacovigilance obligations and in this session We will share some practises on the planning and conduct of the pharmacovigilance Inspection of the different parties involved to focus on some particular areas of concern and bring some thought-provoking ideas to the table for discussion.

Speaker(s)

Amal  Arafah, MPH

Amal Arafah, MPH

Medication Safety Specialist , Saudi Food and Drug Authority, Saudi Arabia

SFDA Inspections – Regulators’ Perspective

Marouane  El Kabaili, PHARMD

Marouane El Kabaili, PHARMD

arab League QPPV & Cluster Safety Lead North West Africa and Middle East, Pfizer, Morocco

Arab League GVP Inspection Pharma Perspectives

Dana  Isleem

Dana Isleem

Pharmacovigilance Manager, Bristol-Myers Squibb , Saudi Arabia

Arab League GVP Inspection Pharma Perspectives

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.